Murray Goldberg

Murray Goldberg

Directeur/Bestuurslid bij AYALA PHARMACEUTICALS, INC.
81 jaar
Health Technology
Consumer Services
Finance

Profiel

Mr. Murray A. Goldberg is an Independent Director at Ayala Pharmaceuticals, Inc. and a Venture Advisor at Israel Biotech Fund.
He is on the Board of Directors at Ayala Pharmaceuticals, Inc. Mr. Goldberg was previously employed as an Independent Director by Ayala Pharmaceuticals, Inc. /Old/, an Independent Director by Teva Pharmaceutical Industries Ltd., an Independent Director by Aerie Pharmaceuticals, Inc., a Senior Vice President-Administration by Regeneron Pharmaceuticals, Inc., a Chief Financial Officer, Treasurer & VP-Finance by PharmaGenics, Inc., and a Managing Director-Structured Finance Group by The Chase Manhattan Bank NA. He also served on the board at Advaxis, Inc. He received his undergraduate degree from New York University, a graduate degree from London School of Economics & Political Science and an MBA from The University of Chicago.

Actieve functies van Murray Goldberg

BedrijvenFunctieBegin
AYALA PHARMACEUTICALS, INC. Directeur/Bestuurslid 01-01-2023
Consultant / Adviseur -

Eerdere bekende functies van Murray Goldberg

BedrijvenFunctieEinde
ADVAXIS, INC. Directeur/Bestuurslid 19-01-2023
AERIE PHARMACEUTICALS, INC. Directeur/Bestuurslid 11-06-2020
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Directeur/Bestuurslid 09-06-2020
REGENERON PHARMACEUTICALS, INC. Financieel Directeur/CFO 03-10-2013
Financieel Directeur/CFO 01-01-1995
Ervaring van Murray Goldberg in detail bekijken

Opleiding van Murray Goldberg

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

69

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Technology

Health Technology

Finance

Health Technology

Commercial Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Murray Goldberg